149 related articles for article (PubMed ID: 9478942)
1. Lithostathine, the presumed pancreatic stone inhibitor, does not interact specifically with calcium carbonate crystals.
De Reggi M; Gharib B; Patard L; Stoven V
J Biol Chem; 1998 Feb; 273(9):4967-71. PubMed ID: 9478942
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic stone protein. II. Implication in stone formation during the course of chronic calcifying pancreatitis.
Multigner L; Sarles H; Lombardo D; De Caro A
Gastroenterology; 1985 Aug; 89(2):387-91. PubMed ID: 3924721
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic stone protein (lithostathine), a physiologically relevant pancreatic calcium carbonate crystal inhibitor?
Bimmler D; Graf R; Scheele GA; Frick TW
J Biol Chem; 1997 Jan; 272(5):3073-82. PubMed ID: 9006958
[TBL] [Abstract][Full Text] [Related]
4. Identification of immunoreactive pancreatic stone protein in pancreatic stone, pancreatic tissue, and pancreatic juice.
Yamadera K; Moriyama T; Makino I
Pancreas; 1990 May; 5(3):255-60. PubMed ID: 2111547
[TBL] [Abstract][Full Text] [Related]
5. [Pancreatic lithogenesis].
Sarles H
Ann Gastroenterol Hepatol (Paris); 1986; 22(1):37-40. PubMed ID: 3963739
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of nucleation and crystal growth of calcium carbonate by human lithostathine.
Bernard JP; Adrich Z; Montalto G; De Caro A; De Reggi M; Sarles H; Dagorn JC
Gastroenterology; 1992 Oct; 103(4):1277-84. PubMed ID: 1397886
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic stone protein, a phosphoprotein which inhibits calcium carbonate precipitation from human pancreatic juice.
Multigner L; De Caro A; Lombardo D; Campese D; Sarles H
Biochem Biophys Res Commun; 1983 Jan; 110(1):69-74. PubMed ID: 6838525
[No Abstract] [Full Text] [Related]
8. Pancreatic lithostathine as a calcite habit modifier.
Geider S; Baronnet A; Cerini C; Nitsche S; Astier JP; Michel R; Boistelle R; Berland Y; Dagorn JC; Verdier JM
J Biol Chem; 1996 Oct; 271(42):26302-6. PubMed ID: 8824282
[TBL] [Abstract][Full Text] [Related]
9. Current status of pancreatic stone protein.
Hayakawa T; Naruse S; Kitagawa M; Nakae Y; Hayakawa S
Nagoya J Med Sci; 1994 Dec; 57(3-4):109-18. PubMed ID: 7898566
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of calcite crystal growth inhibition by the N-terminal undecapeptide of lithostathine.
Gerbaud V; Pignol D; Loret E; Bertrand JA; Berland Y; Fontecilla-Camps JC; Canselier JP; Gabas N; Verdier JM
J Biol Chem; 2000 Jan; 275(2):1057-64. PubMed ID: 10625646
[TBL] [Abstract][Full Text] [Related]
11. The human pancreatic stone protein.
De Caro A; Multigner L; Dagorn JC; Sarles H
Biochimie; 1988 Sep; 70(9):1209-14. PubMed ID: 3147713
[TBL] [Abstract][Full Text] [Related]
12. Etiopathogenesis and definition of chronic pancreatitis.
Sarles H
Dig Dis Sci; 1986 Sep; 31(9 Suppl):91S-107S. PubMed ID: 3525051
[TBL] [Abstract][Full Text] [Related]
13. [Pancreatic lithostathine inhibitor of calcium carbonate precipitation: structure-function relationship].
Bernard JP; Takacs T; de Reggi M; Sarles H; Dagorn JC
Nephrologie; 1993; 14(6):257-9. PubMed ID: 8145882
[TBL] [Abstract][Full Text] [Related]
14. The molecular characteristics of a human pancreatic acidic phosphoprotein that inhibits calcium carbonate crystal growth.
De Caro A; Multigner L; Lafont H; Lombardo D; Sarles H
Biochem J; 1984 Sep; 222(3):669-77. PubMed ID: 6487269
[TBL] [Abstract][Full Text] [Related]
15. Protein-X, Pancreatic Stone-, Pancreatic thread-, reg-protein, P19, lithostathine, and now what? Characterization, structural analysis and putative function(s) of the major non-enzymatic protein of pancreatic secretions.
De Reggi M; Gharib B
Curr Protein Pept Sci; 2001 Mar; 2(1):19-42. PubMed ID: 12369899
[TBL] [Abstract][Full Text] [Related]
16. Human lithostathine S2-5: a relevant inhibitor of pancreatic stone formation?
Bimmler D; Graf R; Frick T
Pancreas; 1999 May; 18(4):417-8. PubMed ID: 10231850
[No Abstract] [Full Text] [Related]
17. Organic matrix of pancreatic stones associated with nutritional pancreatitis.
Montalto G; Multigner L; Sarles H; De Caro A
Pancreas; 1988; 3(3):263-8. PubMed ID: 3387420
[TBL] [Abstract][Full Text] [Related]
18. Calcium carbonate crystals promote calcium oxalate crystallization by heterogeneous or epitaxial nucleation: possible involvement in the control of urinary lithogenesis.
Geider S; Dussol B; Nitsche S; Veesler S; Berthézène P; Dupuy P; Astier JP; Boistelle R; Berland Y; Dagorn JC; Verdier JM
Calcif Tissue Int; 1996 Jul; 59(1):33-7. PubMed ID: 8661982
[TBL] [Abstract][Full Text] [Related]
19. Evidence that human kidney produces a protein similar to lithostathine, the pancreatic inhibitor of CaCO3 crystal growth.
Verdier JM; Dussol B; Casanova P; Daudon M; Dupuy P; Berthezene P; Boistelle R; Berland Y; Dagorn JC
Eur J Clin Invest; 1992 Jul; 22(7):469-74. PubMed ID: 1516594
[TBL] [Abstract][Full Text] [Related]
20. Lithostathine, an inhibitor of CaCO3 crystal growth in pancreatic juice, induces bacterial aggregation.
Iovanna J; Frigerio JM; Dusetti N; Ramare F; Raibaud P; Dagorn JC
Pancreas; 1993 Sep; 8(5):597-601. PubMed ID: 8302796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
